By Dr Sunil Badve

Journal articles

Nadeau-Fredette AC; Johnson DW; Hawley CM; Pascoe EM; Cho Y; Clayton PA; Borlace M; Badve SV; Sud K; Boudville N; McDonald SP, 2016, 'Center-specific factors associated with peritonitis risk—a multi-center registry analysis', Peritoneal Dialysis International, 36, pp. 509 - 518, http://dx.doi.org/10.3747/pdi.2015.00146

Badve SV; Palmer SC; Hawley CM; Pascoe EM; Strippoli GFM; Johnson DW, 2016, 'Glomerular filtration rate decline as a surrogate end point in kidney disease progression trials', Nephrology Dialysis Transplantation, 31, pp. 1425 - 1436, http://dx.doi.org/10.1093/ndt/gfv269

Palmer SC; Mavridis D; Nicolucci A; Johnson DW; Tonelli M; Craig JC; Maggo J; Gray V; De Berardis G; Ruospo M; Natale P; Saglimbene V; Badve SV; Cho Y; Nadeau-Fredette AC; Burke M; Faruque L; Lloyd A; Ahmad N; Liu Y; Tiv S; Wiebe N; Strippoli GFM, 2016, 'Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes a meta-analysis', JAMA Journal of the American Medical Association, 316, pp. 313 - 324, http://dx.doi.org/10.1001/jama.2016.9400

Young V; Balaam S; Orazio L; Bates A; Badve SV; Johnson DW; Campbell KL, 2016, 'Appetite predicts intake and nutritional status in patients receiving peritoneal dialysis', Journal of Renal Care, 42, pp. 123 - 131, http://dx.doi.org/10.1111/jorc.12156

Roberts MA; Pilmore HL; Ierino FL; Badve SV; Cass A; Garg AX; Isbel NM; Krum H; Pascoe EM; Perkovic V; Scaria A; Tonkin AM; Vergara LA; Hawley CM; Levin A; Hare D; Martin A; Wheeler DC; Fulcher G; Brown H; Colquhoun D; Korczyk D; Mather A; Wong A; Bisscheroux P; Gillies A; Garvey L; Tan KS; Lennan E; Pitkin M; Ahearn K; Carroll RP; Scott E; Cooper B; Pearse J; Snelling P; Burman J; Hand S; Pedagogos E; Karschimkus C; Pilmore A; Walker R; Ellis G; Marshall MR; Paul C; Johnson D; Helyar J; Morrish A; Paul-Brent PA; Reidlinger D; Zhang L, 2016, 'The β-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) feasibility study: A randomized controlled trial', American Journal of Kidney Diseases, 67, pp. 902 - 911, http://dx.doi.org/10.1053/j.ajkd.2015.10.029

Zhang L; Liu X; Pascoe EM; Badve SV; Boudville NC; Clayton PA; De Zoysa J; Hawley CM; Kanellis J; McDonald SP; Peh CA; Polkinghorne KR; Johnson DW, 2016, 'Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study', Nephrology, 21, pp. 387 - 396, http://dx.doi.org/10.1111/nep.12629

Sukkar L; Hong D; Wong MG; Badve SV; Perkovic V; Yu X; Hillis GS; Gallagher M; Jardine M, 2016, 'MP221EFFECTS OF ISCHAEMIC CONDITIONING ON MAJOR CLINICAL OUTCOMES IN PEOPLE UNDERGOING INVASIVE PROCEDURES: A SYSTEMATIC REVIEW AND METAANALYSIS', Nephrology Dialysis Transplantation, 31, pp. i413 - i413, http://dx.doi.org/10.1093/ndt/gfw187.27

Viecelli AK; Pascoe EM; Polkinghorne KR; Hawley CM; Paul-Brent PA; Badve SV; Cass A; Johnson DW; Kerr PG; Mori TA; Scaria A; Hooi SL; Ong ML; Irish AB, 2016, 'Baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study', Nephrology, 21, pp. 217 - 228, http://dx.doi.org/10.1111/nep.12573

Zhang L; Coombes J; Pascoe EM; Badve SV; Dalziel K; Cass A; Clarke P; Ferrari P; McDonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM; Johnson DW, 2016, 'The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial', Redox Report, 21, pp. 14 - 23, http://dx.doi.org/10.1179/1351000215Y.0000000022

Sukkar L; Hong D; Wong MG; Badve SV; Rogers K; Perkovic V; Walsh M; Yu X; Hillis GS; Gallagher M; Jardine M, 2016, 'Effects of ischaemic conditioning on major clinical outcomes in people undergoing invasive procedures: Systematic review and meta-analysis', BMJ Online, 355, http://dx.doi.org/10.1136/bmj.i5599

Zhang L; Lee G; Liu X; Pascoe EM; Badve SV; Boudville NC; Clayton PA; Hawley CM; Kanellis J; McDonald SP; Peh CA; Polkinghorne KR; Johnson DW, 2016, 'Long-term outcomes of end-stage kidney disease for patients with lupus nephritis', Kidney International, 89, pp. 1337 - 1345, http://dx.doi.org/10.1016/j.kint.2016.02.014

Zhang L; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; De Zoysa J; Isbel NM; McTaggart S; Morrish AT; Geoffrey Playford E; Scaria A; Snelling P; Vergara LA; Hawley CM; Johnson DW, 2015, 'The effect of exit-site antibacterial honey versus nasal mupirocin prophylaxis on the microbiology and outcomes of peritoneal dialysis-associated peritonitis and exit-site infections: A sub-study of the Honeypot trial', Peritoneal Dialysis International, 35, pp. 712 - 721, http://dx.doi.org/10.3747/pdi.2014.00206

Mallett A; Tang W; Hart G; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Campbell SB; Clayton PA; Johnson DW, 2015, 'End-stage kidney disease due to fibrillary glomerulonephritis and immunotactoid glomerulopathy-Outcomes in 66 consecutive ANZDATA registry cases', American Journal of Nephrology, 42, pp. 177 - 184, http://dx.doi.org/10.1159/000440815

Azzam O; Sud K; Clayton P; Johnson D; Badve S; Borlace M; Mcdonald S; Boudville N, 2015, 'DISPARITIES IN SURVIVAL OF DIALYSIS PATIENTS IN AUSTRALIA BASED UPON ETHNICITY AND COUNTRY OF BIRTH', NEPHROLOGY, 20, pp. 56 - 56, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000360217000142&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Badve SV; Burke M; Clayton P; Campbell SB; Hawley CM; Lim WH; Mcdonald SP; Pascoe E; Wong G; Johnson DW, 2015, 'MAMMALIAN TARGET OF RAPAMYCIN INHIBITORS AND CLINICAL OUTCOMES IN ADULT KIDNEY TRANSPLANT RECIPIENTS', NEPHROLOGY, 20, pp. 48 - 48, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000360217000115&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Badve SV; Zhang L; Coombes JS; Pascoe EM; Cass A; Clarke P; Ferrari P; McDonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM; Johnson DW; D'Almeida E; Fassett R; Kirkpatrick C; Phoon R, 2015, 'Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: A secondary analysis of the HERO trial', Canadian Journal of Kidney Health and Disease, 2, http://dx.doi.org/10.1186/s40697-015-0066-5

Tang W; Grace B; McDonald SP; Hawley CM; Badve SV; Boudville NC; Brown FG; Clayton PA; Johnson DW, 2015, 'Socio-economic status and peritonitis in Australian non-indigenous peritoneal dialysis patients', Peritoneal Dialysis International, 35, pp. 450 - 459, http://dx.doi.org/10.3747/pdi.2013.00004

Viecelli AK; Pascoe E; Polkinghorne KR; Hawley C; Paul-Brent PA; Badve SV; Cass A; Heritier S; Kerr PG; Mori TA; Robertson A; Seong HL; Irish AB, 2015, 'The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: The updated final trial protocol and rationale of post-initiation trial modifications', BMC Nephrology, 16, http://dx.doi.org/10.1186/s12882-015-0089-2

Badve SV; Palmer SC; Johnson DW; Strippoli GFM, 2015, 'A nephrology guide to reading and using systematic reviews of randomized trials', Nephrology Dialysis Transplantation, 30, pp. 878 - 884, http://dx.doi.org/10.1093/ndt/gfu222

Roberts MA; Pilmore HL; Ierino FL; Badve SV; Cass A; Garg AX; Hawley CM; Isbel NM; Krum H; Pascoe EM; Tonkin AM; Vergara LA; Perkovic V, 2015, 'The rationale and design of the Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility Study', Nephrology, 20, pp. 140 - 147, http://dx.doi.org/10.1111/nep.12362

Stevenson S; Tang W; Cho Y; Mudge DW; Hawley CM; Badve SV; Johnson DW, 2015, 'The role of monitoring vancomycin levels in patients with peritoneal dialysis-associated peritonitis', Peritoneal Dialysis International, 35, pp. 222 - 228, http://dx.doi.org/10.3747/pdi.2013.00156

Johnson DW; Pascoe EM; Badve SV; Dalziel K; Cass A; Clarke P; Ferrari P; McDonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM; D'Almeida E; Fassett R; Kirkpatrick C; Phoon R; Tonkin A; Forbes A; Levin A; Wheeler DC; Jardine M; Burman J; Hand S; Garvey L; Suranyi M; Gilbert M; Endre Z; McNamara K; Snelling P; Mahadevan K; Pollock A; Leary D; Ratanjee S; Kirby J; Juneja R; Hill K; Cook N; Bisscheroux P; McMahon L; Kent A; Raspudic M; Steinwandel U; Dogra S; Pellicano S; Paul-Brent PA, 2015, 'A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: The handling erythropoietin resistance with oxpentifylline (HERO) trial', American Journal of Kidney Diseases, 65, pp. 49 - 57, http://dx.doi.org/10.1053/j.ajkd.2014.06.020

Nadeau-Fredette AC; Badve SV; Johnson DW, 2015, 'Daily home hemodialysis: Balancing cardiovascular benefits with infectious harms', American Journal of Kidney Diseases, 65, pp. 6 - 8, http://dx.doi.org/10.1053/j.ajkd.2014.08.012

Lo C; Toyama T; Hirakawa Y; Jun M; Cass A; Hawley C; Pilmore H; Badve S; Perkovic V; Zoungas S, 2015, 'Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease', Cochrane Database of Systematic Reviews

Badve SV; Paul SK; Klein K; Clayton PA; Hawley CM; Brown FG; Boudville N; Polkinghorne KR; McDonald SP; Johnson DW, 2014, 'The association between body mass index and mortality in incident dialysis patients', Plos One, 9, http://dx.doi.org/10.1371/journal.pone.0114897

Mallett A; Tang W; Clayton PA; Stevenson S; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Campbell SB; Johnson DW, 2014, 'End-stage kidney disease due to alport syndrome: Outcomes in 296 consecutive Australia and New Zealand dialysis and transplant registry cases', Nephrology Dialysis Transplantation, 29, pp. 2277 - 2286, http://dx.doi.org/10.1093/ndt/gfu254

Cho Y; Badve SV; Hawley CM; McDonald SP; Brown FG; Boudville N; Clayton P; Johnson DW, 2014, 'Peritoneal dialysis outcomes after temporary haemodialysis transfer for peritonitis', Nephrology Dialysis Transplantation, 29, pp. 1940 - 1947, http://dx.doi.org/10.1093/ndt/gfu050

Johnson DW; Pascoe E; Badve SV; Dalziel K; Cass A; Clarke P; Ferrari P; Mcdonald SP; Morrish AT; Pedagogos E; Perkovic V; Scaria A; Walker R; Vergara LA; Hawley CM, 2014, 'A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF PENTOXIFYLLINE ON ERYTHROPOIESIS STIMULATING AGENT RESISTANCE IN ANAEMIC PATIENTS WITH CHRONIC KIDNEY DISEASE - THE HERO TRIAL', NEPHROLOGY, 19, pp. 29 - 29, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339715700047&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Badve SV; Roberts MA; Palmer SC; Hiremath SS; Hawley CM; Perkovic V; Whalley GA; Strippoli GFM; Johnson DW, 2014, 'INTERVENTIONS FOR REDUCTION OF LEFT VENTRICULAR MASS IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS', NEPHROLOGY, 19, pp. 32 - 32, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339715700056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Zhang L; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; De Zoysa J; Isbel NM; Mctaggart S; Morrish AT; Playford EG; Scaria A; Snelling P; Vergara LA; Hawley CM; Johnson DW, 2014, 'MICROBIOLOGICAL RESULTS OF THE HONEYPOT STUDY - SECONDARY ANALYSIS OF A RANDOMISED, CONTROLLED TRIAL OF EXIT SITE APPLICATION OF MEDIHONEY FOR THE PREVENTION OF CATHETER-ASSOCIATED INFECTIONS IN PD PATIENTS', NEPHROLOGY, 19, pp. 30 - 30, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339715700049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bose B; Badve SV; Hiremath SS; Boudville N; Brown FG; Cass A; De Zoysa JR; Fassett RG; Faull R; Harris DC; Hawley CM; Kanellis J; Palmer SC; Perkovic V; Pascoe EM; Rangan GK; Walker RJ; Walters G; Johnson DW, 2014, 'Effects of uric acid-lowering therapy on renal outcomes: A systematic review and meta-analysis', Nephrology Dialysis Transplantation, 29, pp. 406 - 413, http://dx.doi.org/10.1093/ndt/gft378

Johnson DW; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; de Zoysa J; Isbel NM; McTaggart S; Morrish AT; Playford EG; Scaria A; Snelling P; Vergara LA; Hawley CM, 2014, 'Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): A randomised trial', Lancet Infectious Diseases, 14, pp. 23 - 30, http://dx.doi.org/10.1016/S1473-3099(13)70258-5

Cho Y; Johnson DW; Craig JC; Strippoli GFM; Badve SV; Wiggins KJ, 2014, 'Biocompatible dialysis fluids for peritoneal dialysis', Cochrane Database of Systematic Reviews, 2014, http://dx.doi.org/10.1002/14651858.CD007554.pub2

Cho Y; Johnson DW; Craig JC; Strippoli GFM; Badve SV; Wiggins KJ, 2014, 'Biocompatible dialysis fluids for peritoneal dialysis.', The Cochrane database of systematic reviews, 3

Badve SV; Johnson DW, 2014, 'Chronic kidney disease: haemodialysis catheter care in practice.', Nature Reviews Nephrology, 10, pp. 131 - 133, http://dx.doi.org/10.1038/nrneph.2014.3

Morrish AT; Hawley CM; Johnson DW; Badve SV; Perkovic V; Reidlinger DM; Cass A, 2014, 'Establishing a clinical trials network in nephrology: Experience of the Australasian Kidney Trials Network', Kidney International, 85, pp. 23 - 30, http://dx.doi.org/10.1038/ki.2013.391

Lan PG; Johnson DW; McDonald SP; Boudville N; Borlace M; Badve SV; Sud K; Clayton PA, 2014, 'The association between peritoneal dialysis modality and peritonitis', Clinical Journal of the American Society of Nephrology, 9, pp. 1091 - 1097, http://dx.doi.org/10.2215/CJN.09730913

Tang W; Cho Y; Hawley CM; Badve SV; Johnson DW, 2014, 'The role of monitoring Gentamicin levels in patients with gram-negative peritoneal dialysis-associated peritonitis', Peritoneal Dialysis International, 34, pp. 219 - 226, http://dx.doi.org/10.3747/pdi.2012.00318

Zhang L; Pascoe EM; Badve SV; Cass A; Clarke P; Coombes JS; Ferrari P; Mcdonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM; Johnson DW, 2014, 'THE EFFECT OF PENTOXIFYLLINE ON OXIDATIVE STRESS MARKERS: SUBSTUDY OF THE HERO TRIAL', NEPHROLOGY, 19, pp. 35 - 35

Cho Y; Badve SV; Hawley CM; McDonald SP; Brown FG; Boudville N; Bannister KM; Clayton PA; Johnson DW, 2013, 'Association of biocompatible peritoneal dialysis solutions with peritonitis risk, treatment, and outcomes', Clinical Journal of the American Society of Nephrology, 8, pp. 1556 - 1563, http://dx.doi.org/10.2215/CJN.12361212

Johnson D; Badve S; Pascoe E; Beller E; Cass A; Clark C; De Zoysa J; Mctaggart S; Isbel N; Morrish A, 2013, 'A RANDOMISED, CONTROLLED TRIAL OF EXIT SITE APPLICATION OF MEDIHONEY FOR THE PREVENTION OF CATHETER-ASSOCIATED INFECTIONS IN PD PATIENTS - HONEYPOT STUDY', NEPHROLOGY, 18, pp. 27 - 27, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000323453000049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Badve SV; Beller EM; Cass A; Francis DP; Hawley C; Macdougall IC; Perkovic V; Johnson DW, 2013, 'Interventions for erythropoietin-resistant anaemia in dialysis patients', Cochrane Database of Systematic Reviews, 2013, http://dx.doi.org/10.1002/14651858.CD006861.pub3

Cho Y; Johnson DW; Badve S; Craig JC; Strippoli GFK; Wiggins KJ, 2013, 'Impact of icodextrin on clinical outcomes in peritoneal dialysis: A systematic review of randomized controlled trials', Nephrology Dialysis Transplantation, 28, pp. 1899 - 1907, http://dx.doi.org/10.1093/ndt/gft050

Pascoe EM; Lo S; Scaria A; Badve SV; Beller EM; Cass A; Hawley CM; Johnson DW, 2013, 'The honeypot randomized controlled trial statistical analysis plan', Peritoneal Dialysis International, 33, pp. 426 - 435, http://dx.doi.org/10.3747/pdi.2012.00310

Tang W; Bose B; Mcdonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Clayton PA; Campbell SB; Peh CA; Johnson DW, 2013, 'The outcomes of patients with ESRD and ANCA-associated Vasculitis in Australia and New Zealand', Clinical Journal of the American Society of Nephrology, 8, pp. 773 - 780, http://dx.doi.org/10.2215/CJN.08770812

Tang W; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Clayton PA; Campbell SB; De Zoysa JR; Johnson DW, 2013, 'End-stage renal failure due to amyloidosis: Outcomes in 490 ANZDATA registry cases', Nephrology Dialysis Transplantation, 28, pp. 455 - 461, http://dx.doi.org/10.1093/ndt/gfs492

Tang W; Mcdonald SP; Hawley CM; Badve SV; Boudville NC; Brown FG; Clayton PA; Campbell SB; De Zoysa JR; Johnson DW, 2013, 'Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease', Kidney International, 83, pp. 503 - 510, http://dx.doi.org/10.1038/ki.2012.375

Krishnasamy R; Badve SV; Hawley CM; McDonald SP; Boudville N; Brown FG; Polkinghorne KR; Bannister KM; Wiggins KJ; Clayton P; Johnson DW, 2013, 'Daily variation in death in patients treated by long-term dialysis: Comparison of in-center hemodialysis to peritoneal and home hemodialysis', American Journal of Kidney Diseases, 61, pp. 96 - 103, http://dx.doi.org/10.1053/j.ajkd.2012.07.008

Cho Y; Badve SV; Hawley CM; McDonald SP; Brown FG; Boudville N; Wiggins KJ; Bannister KM; Clayton P; Johnson DW, 2013, 'Effects of climatic region on peritonitis risk, microbiology, treatment, and outcomes: A multicenter registry study', Peritoneal Dialysis International, 33, pp. 75 - 85, http://dx.doi.org/10.3747/pdi.2011.00317

Cho Y; Johnson DW; Badve SV; Craig JC; Strippoli GFM; Wiggins KJ, 2013, 'The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients', Kidney International, 84, pp. 969 - 979, http://dx.doi.org/10.1038/ki.2013.190

Back to profile page